Top Stories
First Report aims to reduce reporting and interpretation times amid growing imaging volumes and workforce shortages.
The company said the findings add to a growing body of evidence that behaviour support may play a key role in modern weight management.
The companies have signed a licensing deal to develop an Alzheimer's blood test using ALZpath's pTau217 antibody.
The FDA-cleared platform pairs with Dexcom's Stelo biosensor to continuously track glucose levels.
The US regulator has authorised EchoNext to detect six types of heart disease using standard 12-lead ECGs.
Conference News
Already adopted in more than 20 countries for fetal brain and heart examinations, Fetoly now introduces Full Fetus Anatomy, becoming the first Real-Time AI Ultrasound Assistant to provide comprehensiv...
At HLTH Europe, executives from Sanofi, Takeda, MSD and TransCelerate came together in a panel discussion to compare notes on where the European pharma sector is at in its digital journey and how it compares with other regions on the global stage.
Showcasing how advanced AI models are transforming clinical development and accelerating precision medicineWALTHAM, Mass.--(BUSINESS WIRE)-- BostonGene, leading developer of AI models for tumor and im...
ASCO Perspective Quote“Prior studies on multi-cancer early detection tests have largely focused on Western populations. This large-scale study across 6 Asian countries showed the potential for cell-fr...
SEC-registered, FINRA-member platform expands capital access for life science innovatorsSAN DIEGO, CA, UNITED STATES, June 22, 2026 /EINPresswire.com/ -- BioTech Social Inc. (BSI) today announced the ...
